Invention Grant
- Patent Title: Proteins having pneumococcal capsule degrading activity and methods of use
-
Application No.: US16636503Application Date: 2018-08-13
-
Publication No.: US11690900B2Publication Date: 2023-07-04
- Inventor: Fikri Y. Avci , Dustin Middleton , Amy Victoria Paschall
- Applicant: UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
- Applicant Address: US GA Athens
- Assignee: UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
- Current Assignee: UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
- Current Assignee Address: US GA Athens
- Agency: Mueting Raasch Group
- International Application: PCT/US2018/046521 2018.08.13
- International Announcement: WO2019/036373A 2019.02.21
- Date entered country: 2020-02-04
- Main IPC: A61K38/47
- IPC: A61K38/47 ; A61P31/04 ; C12N1/20 ; C12N9/24

Abstract:
Provided herein is a protein, referred to as a Pn3Pase protein, that degrades the capsular polysaccharide of serotype 3 Streptococcus pneumoniae. The disclosure includes a genetically modified cell that includes a Pn3Pase protein, and compositions that include the protein, the polynucleotide encoding the protein, the genetically modified cell, or a combination thereof. Also provided are methods for using a Pn3Pase protein, including methods for contacting a S. pneumoniae having a type III capsular polysaccharide with a Pn3Pase protein, increasing deposition of at least one complement component on the surface of a S. pneumoniae, treating an infection in a subject, treating a symptom in a subject, decreasing colonization of a subject by S. pneumoniae, or a combination thereof.
Public/Granted literature
- US20210308233A1 PROTEINS HAVING PNEUMOCOCCAL CAPSULE DEGRADING ACTIVITY AND METHODS OF USE Public/Granted day:2021-10-07
Information query
IPC分类: